Peter Hanlon

3 weeks ago | thelancet.com | Giuseppe Maltese |Helier Hospitals |Peter Hanlon

CorrespondenceVolume 13, Issue 5p370-371 aSchool of Cardiovascular Medicine & Sciences, King's College London, London SE1 9NH, UK bDepartment of Diabetes and Endocrinology, Epsom & St Helier University Hospitals, Surrey, UK cDepartment of Diabetes and Endocrinology, Guy's and St Thomas' NHS Trust, London, UK dDepartment of Metabolism, Digestion & Reproduction, Imperial College London, London, UK eDepartment of Diabetes and Endocrinology, St Mary's Hospital, Imperial College Healthcare NHS...

1 month ago | theage.com.au | Peter Hanlon

, register or subscribe to save articles for later. Save articles for laterAdd articles to your saved list and come back to them any time. Michael Barlow’s birth as an AFL footballer was so laboured, it’s hard to imagine the end could have been just as harrowing. Delisted by Gold Coast in 2018, nine seasons and 141 games after one of the most storied late-blooming careers had begun, Barlow headed home to Shepparton to be with his dying mother. He needed a family’s guiding hand more than ever.

1 month ago | aicd.com.au | Peter Hanlon

Being a director has become more demanding than ever. Factor in committee involvement and the workload can become increasingly burdensome. So how many board seats is too many? A fast-moving regulatory environment, technological shifts and economic uncertainty has made holding a seat in the boardroom more exacting than ever. Managing multiple directorships is a juggling act demanding increased dexterity.

Feb 14, 2025 | aicd.com.au | Peter Hanlon

Last week, US President Donald Trump said his administration would introduce tariffs of 25 per cent on steel and aluminium imports into the United States, later revealing this would include “reciprocal” tariffs on US trading partners which would be “fair to all”. Yet even as the impact on Australia remains unclear, experts are urging boardrooms to ignore the noise and continue to stay the course and govern with pragmatism.

Feb 3, 2025 | healio.com | Michael Monostra |Richard Smith |Peter Hanlon

Key takeaways: GLP-1 receptor agonists conferred greater HbA1c reductions in older adults than younger adults. Older adults had a lower risk for major adverse CV events than younger adults with SGLT2 inhibitors. SGLT2 inhibitors confer greater risk reductions for major adverse cardiovascular events in older adults with type 2 diabetes compared with younger adults, according to findings from a systematic review and meta-analysis published in JAMA.